Equine N-MID OC antibody and antigen (recombinant protein)
Diagnostic anti-Equine N-MID OC antibodies pairs and antigen for animal health (animal Equine/Horse osteoporosis) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-N-MID-OC-Ag01 | Recombinant Equine N-MID OC protein | 3090 |
GMP-EQU-N-MID-OC-Ab01 | Anti-Equine N-MID OC mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-N-MID-OC-Ab02 | Anti-Equine N-MID OC mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-N-MID-OC-Ab03 | Anti-Equine N-MID OC human monoclonal antibody (mAb) | 1953 |
GMP-EQU-N-MID-OC-Ab04 | Anti-Equine N-MID OC human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-EQU-N-MID-OC-Ag01 |
Product Name | Recombinant Equine N-MID OC protein |
Target/Biomarker | Equine N-terminal midfragment of Osteocalcin (N-MID OC) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine N-terminal midfragment of Osteocalcin antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in N-MID OC level test of animal Equine/Horse with osteoporosis. |
Tag | His |
Products description | Recombinant Equine N-MID OC protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-N-MID-OC-Ab01, GMP-EQU-N-MID-OC-Ab02 |
Product Name | Anti-Equine N-MID OC mouse monoclonal antibody (mAb) |
Target/Biomarker | Equine N-terminal midfragment of Osteocalcin (N-MID OC) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine N-terminal midfragment of Osteocalcin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-N-MID OC antibodies in N-MID OC level test of animal Equine/Horse with osteoporosis. |
Tag | mFc |
Products description | Anti-Equine N-MID OC mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-N-MID OC antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-N-MID-OC-Ab03, GMP-EQU-N-MID-OC-Ab04 |
Product Name | Anti-Equine N-MID OC human monoclonal antibody (mAb) |
Target/Biomarker | Equine N-terminal midfragment of Osteocalcin (N-MID OC) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Equine N-terminal midfragment of Osteocalcin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-N-MID OC antibodies in N-MID OC level test of animal Equine/Horse with osteoporosis. |
Tag | hFc |
Products description | Anti-Equine N-MID OC human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-N-MID OC antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Equine N-MID Osteocalcin (Equine N-MID OC) stands as a cornerstone of equine bone health. Within the vast and powerful physique of the horse, this biomarker plays an indispensable role in ensuring the structural integrity of the skeletal system. It is a fragment of the larger osteocalcin molecule, residing within the Equus ferus caballus species. At its core, Equine N-MID OC is a regulator of bone mineralization and turnover. Its presence and activity are pivotal in orchestrating the formation of hydroxyapatite crystals, the mineral matrix that fortifies equine bones. This mineralization process is fundamental to sustaining the strength and durability required for horses to gallop, jump, and carry out their remarkable feats. Osteocalcin itself is synthesized predominantly by osteoblasts, the dedicated bone-forming cells within the equine body. Equine N-MID OC, arising from the central region of the osteocalcin molecule, represents a nexus of control in the intricate web of bone metabolism.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.